Published in News

First medical tricorder by Scanadu

by on15 July 2013 1731 times

Scientists, doctors and engineers from the American company Scanadu at the IndieGoGo website published Scanadu Scout project, which they say, is "the first medical diagnostic tricorder." Once they have published their project on the famous "crowdsourcing" website, they sought investment in the amount of $100,000. On this day, six days before the end of their campaign, the project has collected over $1,470,000, which is more than enough to bring it to market, where it will be sold at a price of $200.

Although in all promotional materials they use the word tricorder, it is clear that this device is not a gadget from the legendary Star Trek TV series. But on the other hand, given that the sensors are devices able to monitor your heart rate rhythm, body temperature, Sp02 (peripheral blood oxygen saturation), respiration, blood pressure, ECG, and the level of emotional stress, this is a pretty advanced diagnostic device intended for "domestic purposes" that can perform preliminary tests of these body functions, so if it finds some "abnormalities" it will advise you go to the doctor for a detailed examinations.

Device works via Bluetooth with the Scout application for iOS and Android smart phones, which will show you all the desired results on the screen of mobile phones, and the company says it is based on 32-bit Micrium RTOS platform, the same used by NASA instrument SAM (Sample Analysis at Mars) to test samples of Mars soil.
kid screens
It should be noted that Scanadu Scout will not be able to arrive to free market as a medical device, because to become a medical device such a thing should undergo thorough testing and studies of U.S. Food and Drug Administration (FDA), which approves medical devices and diagnostic devices, but from Scanadu say that that is precisely their intention when they collect the necessary funds to launch scientific and clinical studies. They also noted that those who support their investment project will have a right to respond if they want to engage themselves in studies and clinical trials, so they cann accelerate approval process by the FDA.

What do you think? Tell us in our Forum

Last modified on 15 July 2013
Rate this item
(0 votes)

Leave a comment

Make sure you enter all the required information, indicated by an asterisk (*). HTML code is not allowed.